Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas

Jingbo Qiao, Jeremy Cree, Junghee Kang, Sunghoon Kim, B. Mark Evers, Dai H. Chung

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background We have demonstrated that gastrin-releasing peptide (GRP) binds specifically to its cell surface receptor, GRP-R, to act as an autocrine/paracrine growth factor for neuroblastomas (NBs); an increased expression of GRP-R was found in more advanced-stage NBs. Ets family proteins are nuclear targets for intracellular kinase pathways that can lead to cell proliferation; however, a potential role of Ets in the expression of GRP-R in NBs is unknown. Therefore, the purpose of our study was to determine whether Ets regulates transcriptional activity of GRP-R in NBs. Methods We identified multiple DNA-binding sites for various nuclear transcription factors in the proximal (ie, 263 bp) GRP-R promoter. Luciferase assay was performed to measure GRP-R promoter activity that contained site-specific mutations of various binding elements. Electrophoretic mobility shift assay was performed to determine transcription factor-binding activity. Results Mutation of a consensus Ets-binding site in the GRP-R promoter significantly decreased GRP-R promoter activity. Electrophoretic mobility shift assay demonstrated a decrease in Ets nuclear protein-binding activity. Furthermore, overexpression of Ets1 resulted in upregulation of GRP-R promoter activity. Conclusions Our results demonstrate that Ets is a transcription factor that significantly contributes to the GRP-R transcription in NBs. This finding may allow us to develop novel molecular tools to downregulate expression of GRP-R and hence inhibit mitogenic effects of GRP in NBs.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalSurgery
Volume136
Issue number2
DOIs
StatePublished - Aug 1 2004
Externally publishedYes

Fingerprint

Bombesin Receptors
Gastrin-Releasing Peptide
Neuroblastoma
Transcription Factors
Electrophoretic Mobility Shift Assay
Nuclear Proteins
Binding Sites
Mutation
Cell Surface Receptors
Luciferases
Nuclear Family
Protein Binding

ASJC Scopus subject areas

  • Surgery

Cite this

Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas. / Qiao, Jingbo; Cree, Jeremy; Kang, Junghee; Kim, Sunghoon; Evers, B. Mark; Chung, Dai H.

In: Surgery, Vol. 136, No. 2, 01.08.2004, p. 489-494.

Research output: Contribution to journalArticle

Qiao, Jingbo ; Cree, Jeremy ; Kang, Junghee ; Kim, Sunghoon ; Evers, B. Mark ; Chung, Dai H. / Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas. In: Surgery. 2004 ; Vol. 136, No. 2. pp. 489-494.
@article{ba2da14876ae46e4ae2c15eea4082f9f,
title = "Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas",
abstract = "Background We have demonstrated that gastrin-releasing peptide (GRP) binds specifically to its cell surface receptor, GRP-R, to act as an autocrine/paracrine growth factor for neuroblastomas (NBs); an increased expression of GRP-R was found in more advanced-stage NBs. Ets family proteins are nuclear targets for intracellular kinase pathways that can lead to cell proliferation; however, a potential role of Ets in the expression of GRP-R in NBs is unknown. Therefore, the purpose of our study was to determine whether Ets regulates transcriptional activity of GRP-R in NBs. Methods We identified multiple DNA-binding sites for various nuclear transcription factors in the proximal (ie, 263 bp) GRP-R promoter. Luciferase assay was performed to measure GRP-R promoter activity that contained site-specific mutations of various binding elements. Electrophoretic mobility shift assay was performed to determine transcription factor-binding activity. Results Mutation of a consensus Ets-binding site in the GRP-R promoter significantly decreased GRP-R promoter activity. Electrophoretic mobility shift assay demonstrated a decrease in Ets nuclear protein-binding activity. Furthermore, overexpression of Ets1 resulted in upregulation of GRP-R promoter activity. Conclusions Our results demonstrate that Ets is a transcription factor that significantly contributes to the GRP-R transcription in NBs. This finding may allow us to develop novel molecular tools to downregulate expression of GRP-R and hence inhibit mitogenic effects of GRP in NBs.",
author = "Jingbo Qiao and Jeremy Cree and Junghee Kang and Sunghoon Kim and Evers, {B. Mark} and Chung, {Dai H.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/j.surg.2004.05.030",
language = "English (US)",
volume = "136",
pages = "489--494",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas

AU - Qiao, Jingbo

AU - Cree, Jeremy

AU - Kang, Junghee

AU - Kim, Sunghoon

AU - Evers, B. Mark

AU - Chung, Dai H.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Background We have demonstrated that gastrin-releasing peptide (GRP) binds specifically to its cell surface receptor, GRP-R, to act as an autocrine/paracrine growth factor for neuroblastomas (NBs); an increased expression of GRP-R was found in more advanced-stage NBs. Ets family proteins are nuclear targets for intracellular kinase pathways that can lead to cell proliferation; however, a potential role of Ets in the expression of GRP-R in NBs is unknown. Therefore, the purpose of our study was to determine whether Ets regulates transcriptional activity of GRP-R in NBs. Methods We identified multiple DNA-binding sites for various nuclear transcription factors in the proximal (ie, 263 bp) GRP-R promoter. Luciferase assay was performed to measure GRP-R promoter activity that contained site-specific mutations of various binding elements. Electrophoretic mobility shift assay was performed to determine transcription factor-binding activity. Results Mutation of a consensus Ets-binding site in the GRP-R promoter significantly decreased GRP-R promoter activity. Electrophoretic mobility shift assay demonstrated a decrease in Ets nuclear protein-binding activity. Furthermore, overexpression of Ets1 resulted in upregulation of GRP-R promoter activity. Conclusions Our results demonstrate that Ets is a transcription factor that significantly contributes to the GRP-R transcription in NBs. This finding may allow us to develop novel molecular tools to downregulate expression of GRP-R and hence inhibit mitogenic effects of GRP in NBs.

AB - Background We have demonstrated that gastrin-releasing peptide (GRP) binds specifically to its cell surface receptor, GRP-R, to act as an autocrine/paracrine growth factor for neuroblastomas (NBs); an increased expression of GRP-R was found in more advanced-stage NBs. Ets family proteins are nuclear targets for intracellular kinase pathways that can lead to cell proliferation; however, a potential role of Ets in the expression of GRP-R in NBs is unknown. Therefore, the purpose of our study was to determine whether Ets regulates transcriptional activity of GRP-R in NBs. Methods We identified multiple DNA-binding sites for various nuclear transcription factors in the proximal (ie, 263 bp) GRP-R promoter. Luciferase assay was performed to measure GRP-R promoter activity that contained site-specific mutations of various binding elements. Electrophoretic mobility shift assay was performed to determine transcription factor-binding activity. Results Mutation of a consensus Ets-binding site in the GRP-R promoter significantly decreased GRP-R promoter activity. Electrophoretic mobility shift assay demonstrated a decrease in Ets nuclear protein-binding activity. Furthermore, overexpression of Ets1 resulted in upregulation of GRP-R promoter activity. Conclusions Our results demonstrate that Ets is a transcription factor that significantly contributes to the GRP-R transcription in NBs. This finding may allow us to develop novel molecular tools to downregulate expression of GRP-R and hence inhibit mitogenic effects of GRP in NBs.

UR - http://www.scopus.com/inward/record.url?scp=3843078730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843078730&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2004.05.030

DO - 10.1016/j.surg.2004.05.030

M3 - Article

C2 - 15300220

AN - SCOPUS:3843078730

VL - 136

SP - 489

EP - 494

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 2

ER -